Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. […]
Patent delisted for Boehringer Ingelheim drug JENTADUETO Read Post »
Annual Drug Patent Expirations for TUDORZA+PRESSAIR Tudorza Pressair is a drug marketed by Circassia and is included in one NDA.
Patent delisted for Circassia drug TUDORZA PRESSAIR Read Post »
Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug JARDIANCE Read Post »
Annual Drug Patent Expirations for TARGINIQ Targiniq is a drug marketed by Purdue Pharma Lp and is included in one
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug OFEV Read Post »
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug GLYXAMBI Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs.
Patent delisted for Astrazeneca Ab drug BYDUREON Read Post »
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one
Patent delisted for Astrazeneca Ab drug BYDUREON PEN Read Post »
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It
Get fresh news and insights, drug patent expirations & more…
